Volume 27, Number 8—August 2021
Considerations for Establishing Successful Coronavirus Disease Vaccination Programs in Africa
||Tax revenues (national or subnational) for current spending||Project grants from bilateral or multilateral agencies|
|Tax revenues (national or subnational) for repaying domestically or internationally held debt||Grant portion of development loans|
|Social health insurance (compulsory)
||Debt relief proceeds|
|Private||User fees (out of pocket, direct employer payment)||Vaccine fund|
|Cross-subsidies||Project grants from philanthropic institutions|
|Health insurance||Contributions (often in-kind) from vaccine manufacturers|
*COVID-19, coronavirus disease.
Page created: May 27, 2021
Page updated: July 18, 2021
Page reviewed: July 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.